Back to Search
Start Over
Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders
- Source :
- Molecular imaging and biology. 13(6)
- Publication Year :
- 2010
-
Abstract
- There have been several endeavors made to investigate the potential role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography (FDG-PET) (and tracers) and PET-computed tomography imaging in various benign disorders, particularly those related to thoracic structures. These various conditions can be broadly categorized into three groups: (a) infectious diseases (mycobacterial, fungal, bacterial infection), (b) active granulomatous disease such as sarcoidosis, and (c) other non-infectious/inflammatory conditions or proliferative disorders (e.g., radiation pneumonitis, post-lung transplant lymphoproliferative disorders, occupational pleuropulmonary complications, and post-surgical conditions), all of which can demonstrate varying degrees of FDG uptake on PET scans based upon the degree of inflammatory activity. This article reviews the current state of this very important application of FDG-PET imaging.
- Subjects :
- Cancer Research
medicine.medical_specialty
Pathology
Tuberculosis
Lymphoproliferative disorders
Non malignant
Multimodal Imaging
Thoracic Diseases
Fluorodeoxyglucose F18
Medicine
Humans
Radiology, Nuclear Medicine and imaging
Radiation Pneumonitis
Inflammation
PET-CT
medicine.diagnostic_test
business.industry
medicine.disease
Oncology
Granulomatous disease
Positron emission tomography
Positron-Emission Tomography
Radiology
Sarcoidosis
Drug Monitoring
business
Tomography, X-Ray Computed
Subjects
Details
- ISSN :
- 18602002
- Volume :
- 13
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Molecular imaging and biology
- Accession number :
- edsair.doi.dedup.....9a43fd3f18de34803621e45f014c37c0